Cone Photoreceptor Reprogramming from Müller Glia Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for retinal degenerative diseases, such as retinitis pigmentosa and age-related macular degeneration, fail to restore normal vision due to the low integration efficiency of transplanted photoreceptor cells, highlighting the need for new therapeutic approaches to regenerate cone photoreceptors.
Innovation Solution
Generation of recombinant cone photoreceptors by modifying mammalian neuroepithelial cells to express IKAROS Family Zinc Finger 4 (Ikzf4) and co-expressing IKAROS Family Zinc Finger 1 (Ikzf1) in glial cells, such as Müller glia, using vectors like adeno-associated virus (AAV) to reprogram these cells into cone photoreceptors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If photoreceptor transplantation is performed to restore vision, then the number of photoreceptor cells is increased, but the integration efficiency of transplanted cells remains low
Solution Approach 1:
The patent enables endogenous Müller glial cells to reprogram themselves into functional cone photoreceptors through viral delivery of transcription factors (Ikzf1, Ikzf4, and/or Myt1l). This self-service mechanism eliminates the need for external cell transplantation and achieves high efficiency since the cells originate from within the retina itself, solving both the quantity and integration efficiency problems simultaneously.
Solution Approach 2:
Instead of transplanting external photoreceptor cells into the retina (conventional approach), the patent inverts the strategy by transforming existing retinal glial cells into photoreceptors. This inversion approach addresses the integration failure by using cells that are already part of the retinal ecosystem, ensuring proper integration and function.
2Quantity of substance
If external photoreceptor cells are transplanted to replenish lost cells, then vision restoration is attempted, but the transplanted cells fail to integrate properly into the retinal structure
Solution Approach 1:
The endogenous reprogramming approach allows Müller glial cells to autonomously transform into cone photoreceptors without requiring external transplantation procedures. The cells naturally integrate into the retinal structure since they originate from the retinal glial population, eliminating the integration problems associated with external cell transplantation.
Solution Approach 2:
Viral vectors serve as intermediaries to deliver transcription factor genes into Müller glial cells, mediating the transformation process. This intermediary approach enables controlled and efficient reprogramming while ensuring the transformed cells maintain proper retinal integration and function.
3Quantity of substance
If conventional transplantation methods are used to restore photoreceptors, then some cell replacement is achieved, but the treatment complexity and procedural difficulty increase
Solution Approach 1:
The endogenous reprogramming method eliminates the need for complex cell isolation, culture, and transplantation procedures. By delivering viral vectors directly to the retina, Müller glial cells self-transform into photoreceptors in situ, dramatically simplifying the treatment procedure while achieving effective cell replacement.
Solution Approach 2:
The viral vectors are pre-engineered to contain all necessary transcription factor genes (Ikzf1, Ikzf4, and/or Myt1l) required for photoreceptor transformation. This preliminary preparation of the viral construct enables direct in vivo reprogramming without requiring complex ex vivo cell manipulation procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method effectively reprograms neuroepithelial and glial cells into cone photoreceptors, potentially restoring vision by replenishing lost light-sensing cells in the retina, addressing the integration limitations of previous transplantation methods.
Implementation Method 1
modifying mammalian neuroepithelial cells so that they recombinantly express IKAROS Family Zinc Finger 4 (Ikzf4). It also reports the generation (production) of neurons (e.g., cone photoreceptors-like cells) in vitro, ex vivo, and in vivo by modifying mammalian glial cells (e.g., Müller glia cells) so that they recombinantly co-express IKAROS Family Zinc Finger 1 (Ikzf1) and IKAROS Family Zinc Finger 4 (Ikzf4)
Data Source
AI summary
The instant disclosure provides a recombinant nervous system cell comprising nucleic acid encoding IKAROS Family Zinc Finger 4 (Ikzf4) and/or IKAROS Family Zinc Finger 1 (Ikzf1)); a vector comprising a glial specific promotor operably-linked to a nucleic acid molecule encoding IKAROS Family Zinc Finger 1 (Ikzf1) and/or a nucleic acid molecule encoding IKAROS Family Zinc Finger 4 (Ikzf4); and methods of producing a recombinant cone photoreceptor, comprising: (A) (a) introducing a nucleic acid molecule encoding IKAROS Family Zinc Finger 1 (Ikzf1) in a Müller glia cell; and (b) introducing a nucleic acid molecule encoding IKAROS Family Zinc Finger 4 (Ikzf4) in the Müller glia cell; or (B) introducing a nucleic acid molecule encoding Ikzf4 in a retinal neuroepithelial cell; whereby the retinal neuroepithelial cell or the Müller glia is reprogrammed into a recombinant cone photoreceptor.